Cargando…
Manifestation of Subclinical Extrapulmonary Tuberculosis after COVID-19 Vaccination as Supraclavicular Lymphadenopathy
Lymphadenopathy after coronavirus disease 2019 (COVID-19) vaccination is a common side effect that usually resolves within several days to weeks, and only observation is recommended. However, for prolonged lymphadenopathy, other possibilities, including malignancy or other lymphoproliferative diseas...
Autores principales: | Cha, Han Gyu, Kim, Dong Gyu, Choi, Joon Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230702/ https://www.ncbi.nlm.nih.gov/pubmed/35746572 http://dx.doi.org/10.3390/vaccines10060964 |
Ejemplares similares
-
Supraclavicular Lymphadenopathy: Initial Manifestation of Metastasis in Carcinoma of Cervix
por: Tunio, Mutahir A., et al.
Publicado: (2013) -
Coronavirus-vaccine: Supraclavicular lymphadenopathy: 2 case reports
Publicado: (2022) -
Unusual Manifestation of Extrapulmonary Tuberculosis
por: Alghamdi, Aisha A., et al.
Publicado: (2013) -
Supraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up using ultrasonography
por: Kim, Bomi, et al.
Publicado: (2021) -
Supraclavicular lymphadenopathy secondary to COVID-19 BNT162b2 vaccine
por: Roca, B, et al.
Publicado: (2021)